Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
LAVA Therapeutics (LVTX)
NASDAQ:LVTX
Holding LVTX?
Track your performance easily
LVTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.35 - $6.47
Previous Close$1.56
Volume25.12K
Average Volume (3M)49.40K
Market Cap
$40.88M
Enterprise Value-$48.37M
Total Cash (Recent Filing)$95.57M
Total Debt (Recent Filing)$6.31M
Price to Earnings (P/E)―
Beta1.76
Next Earnings
Mar 20, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding26,289,087
10 Day Avg. Volume40,365
30 Day Avg. Volume49,396
Standard Deviation0.27
R-Squared0.00723
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.80
Price to Sales (P/S)6.33
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-3.08
Enterprise Value/Gross Profit-14.72
Enterprise Value/Ebitda5.42
Forecast
1Y Price Target
$6.00Price Target Upside294.74% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
LAVA Therapeutics News
PremiumCompany Announcements
LAVA Therapeutics Faces Financial Hurdles
PremiumPre-Earnings
Is LVTX a Buy, Before Earnings?PremiumCompany Announcements
LAVA Therapeutics Shareholders Approve Key Resolutions
PremiumCompany Announcements
LAVA Therapeutics’ Innovative Gammabody® Cancer Therapy
PremiumCompany Announcements
LAVA Therapeutics Narrows Losses, Grows ProfitOwnership Overview
―
Insiders
2.98% Mutual Funds
12.31% Other Institutional Investors
84.71% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LVTX FAQ
What was LAVA Therapeutics’s price range in the past 12 months?
LAVA Therapeutics lowest stock price was $1.35 and its highest was $6.47 in the past 12 months.
What is LAVA Therapeutics’s market cap?
Currently, no data Available
When is LAVA Therapeutics’s upcoming earnings report date?
LAVA Therapeutics’s upcoming earnings report date is Mar 20, 2025 which is in 118 days.
How were LAVA Therapeutics’s earnings last quarter?
Currently, no data Available
Is LAVA Therapeutics overvalued?
According to Wall Street analysts LAVA Therapeutics’s price is currently Undervalued.
Does LAVA Therapeutics pay dividends?
LAVA Therapeutics does not currently pay dividends.
What is LAVA Therapeutics’s EPS estimate?
LAVA Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LAVA Therapeutics have?
LAVA Therapeutics has 26,292,187 shares outstanding.
What happened to LAVA Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of LAVA Therapeutics?
Among the largest hedge funds holding LAVA Therapeutics’s share is Bruce & Co., Inc.. It holds LAVA Therapeutics’s shares valued at 1M.
---
LAVA Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (294.74% Upside)
$6.00 (294.74% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.0%
Last 30 Days ▼ 2.1%
Last 30 Days ▼ 2.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
3.66%
12-Months-Change
Fundamentals
Return on Equity
-45.30%
Trailing 12-Months
Asset Growth
-24.69%
Trailing 12-Months
Company Description
LAVA Therapeutics
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.
---
LVTX Stock 12 Month Forecast
Average Price Target
$6.00
▲(294.74% Upside)
Technical Analysis
Best Analysts Covering LVTX
1 Year
1 Year Success Rate
4/10 ratings generated profit
1 Year Average Return
-13.99%
reiterated a buy rating 5 months ago
Copying Arthur He CFA's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -13.99% per trade.
---